nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—SLCO1B3—Paclitaxel—kidney cancer	0.0998	0.136	CbGbCtD
Gadoxetate—ABCC3—Vincristine—kidney cancer	0.0969	0.132	CbGbCtD
Gadoxetate—SLCO1B1—Pazopanib—kidney cancer	0.089	0.121	CbGbCtD
Gadoxetate—ABCC4—Sorafenib—kidney cancer	0.0763	0.104	CbGbCtD
Gadoxetate—ABCC4—Sunitinib—kidney cancer	0.0618	0.0842	CbGbCtD
Gadoxetate—ABCC3—Doxorubicin—kidney cancer	0.0606	0.0826	CbGbCtD
Gadoxetate—ABCC2—Paclitaxel—kidney cancer	0.0511	0.0696	CbGbCtD
Gadoxetate—ABCC2—Sorafenib—kidney cancer	0.0454	0.0618	CbGbCtD
Gadoxetate—ABCC2—Vinblastine—kidney cancer	0.0448	0.0611	CbGbCtD
Gadoxetate—ABCC2—Vincristine—kidney cancer	0.044	0.06	CbGbCtD
Gadoxetate—ABCC2—Sunitinib—kidney cancer	0.0368	0.0501	CbGbCtD
Gadoxetate—ABCC2—Doxorubicin—kidney cancer	0.0275	0.0375	CbGbCtD
Gadoxetate—ABCC3—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000566	0.024	CbGpPWpGaD
Gadoxetate—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000532	0.0225	CbGpPWpGaD
Gadoxetate—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000449	0.019	CbGpPWpGaD
Gadoxetate—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000421	0.0178	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—CDH6—kidney cancer	0.000401	0.017	CbGpPWpGaD
Gadoxetate—ABCC2—Irinotecan Pathway—APC—kidney cancer	0.000378	0.016	CbGpPWpGaD
Gadoxetate—SLCO1B1—Irinotecan Pathway—APC—kidney cancer	0.000355	0.015	CbGpPWpGaD
Gadoxetate—ABCC3—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000341	0.0144	CbGpPWpGaD
Gadoxetate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000325	0.0138	CbGpPWpGaD
Gadoxetate—ABCC3—ABC-family proteins mediated transport—ABCB1—kidney cancer	0.000311	0.0131	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—NF2—kidney cancer	0.000304	0.0129	CbGpPWpGaD
Gadoxetate—ABCC4—ABC-family proteins mediated transport—ABCB1—kidney cancer	0.000292	0.0124	CbGpPWpGaD
Gadoxetate—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000271	0.0115	CbGpPWpGaD
Gadoxetate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000258	0.0109	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—SLC5A3—kidney cancer	0.000252	0.0107	CbGpPWpGaD
Gadoxetate—ABCC2—ABC-family proteins mediated transport—ABCB1—kidney cancer	0.000246	0.0104	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—SLC5A3—kidney cancer	0.000237	0.01	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—KEAP1—kidney cancer	0.00022	0.00932	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—KEAP1—kidney cancer	0.000207	0.00876	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—SLC5A3—kidney cancer	0.0002	0.00846	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000176	0.00745	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—KEAP1—kidney cancer	0.000175	0.00739	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—IGF2—kidney cancer	0.000158	0.00671	CbGpPWpGaD
Gadoxetate—Hypoaesthesia—Capecitabine—kidney cancer	0.000157	0.000649	CcSEcCtD
Gadoxetate—Tremor—Paclitaxel—kidney cancer	0.000157	0.000648	CcSEcCtD
Gadoxetate—Hypersensitivity—Sorafenib—kidney cancer	0.000156	0.000643	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000156	0.00659	CbGpPWpGaD
Gadoxetate—Anorexia—Gemcitabine—kidney cancer	0.000156	0.000643	CcSEcCtD
Gadoxetate—Vomiting—Vinblastine—kidney cancer	0.000155	0.000642	CcSEcCtD
Gadoxetate—Dizziness—Erlotinib—kidney cancer	0.000155	0.000642	CcSEcCtD
Gadoxetate—Ill-defined disorder—Paclitaxel—kidney cancer	0.000155	0.000642	CcSEcCtD
Gadoxetate—Connective tissue disorder—Capecitabine—kidney cancer	0.000155	0.000641	CcSEcCtD
Gadoxetate—Vomiting—Everolimus—kidney cancer	0.000155	0.00064	CcSEcCtD
Gadoxetate—Renal impairment—Doxorubicin—kidney cancer	0.000155	0.000638	CcSEcCtD
Gadoxetate—Paraesthesia—Vincristine—kidney cancer	0.000154	0.000638	CcSEcCtD
Gadoxetate—Agitation—Paclitaxel—kidney cancer	0.000154	0.000636	CcSEcCtD
Gadoxetate—Rash—Everolimus—kidney cancer	0.000154	0.000634	CcSEcCtD
Gadoxetate—Dermatitis—Everolimus—kidney cancer	0.000153	0.000634	CcSEcCtD
Gadoxetate—Headache—Vinblastine—kidney cancer	0.000153	0.000633	CcSEcCtD
Gadoxetate—Headache—Everolimus—kidney cancer	0.000153	0.00063	CcSEcCtD
Gadoxetate—Hypotension—Gemcitabine—kidney cancer	0.000152	0.00063	CcSEcCtD
Gadoxetate—Body temperature increased—Dactinomycin—kidney cancer	0.000152	0.000629	CcSEcCtD
Gadoxetate—Abdominal pain—Dactinomycin—kidney cancer	0.000152	0.000629	CcSEcCtD
Gadoxetate—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000152	0.000628	CcSEcCtD
Gadoxetate—Asthenia—Sorafenib—kidney cancer	0.000152	0.000627	CcSEcCtD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF2—kidney cancer	0.000151	0.00639	CbGpPWpGaD
Gadoxetate—Malaise—Paclitaxel—kidney cancer	0.000151	0.000624	CcSEcCtD
Gadoxetate—Vertigo—Paclitaxel—kidney cancer	0.00015	0.000621	CcSEcCtD
Gadoxetate—Syncope—Paclitaxel—kidney cancer	0.00015	0.00062	CcSEcCtD
Gadoxetate—Cerebrovascular accident—Doxorubicin—kidney cancer	0.00015	0.00062	CcSEcCtD
Gadoxetate—Hypersensitivity—Sunitinib—kidney cancer	0.00015	0.000619	CcSEcCtD
Gadoxetate—Decreased appetite—Vincristine—kidney cancer	0.00015	0.000618	CcSEcCtD
Gadoxetate—Pruritus—Sorafenib—kidney cancer	0.00015	0.000618	CcSEcCtD
Gadoxetate—Vomiting—Erlotinib—kidney cancer	0.000149	0.000617	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Vincristine—kidney cancer	0.000149	0.000614	CcSEcCtD
Gadoxetate—Fatigue—Vincristine—kidney cancer	0.000148	0.000613	CcSEcCtD
Gadoxetate—Rash—Erlotinib—kidney cancer	0.000148	0.000612	CcSEcCtD
Gadoxetate—Dermatitis—Erlotinib—kidney cancer	0.000148	0.000611	CcSEcCtD
Gadoxetate—Palpitations—Paclitaxel—kidney cancer	0.000148	0.000611	CcSEcCtD
Gadoxetate—Headache—Erlotinib—kidney cancer	0.000147	0.000608	CcSEcCtD
Gadoxetate—Loss of consciousness—Paclitaxel—kidney cancer	0.000147	0.000608	CcSEcCtD
Gadoxetate—Constipation—Vincristine—kidney cancer	0.000147	0.000608	CcSEcCtD
Gadoxetate—Paraesthesia—Gemcitabine—kidney cancer	0.000147	0.000605	CcSEcCtD
Gadoxetate—Flushing—Capecitabine—kidney cancer	0.000146	0.000605	CcSEcCtD
Gadoxetate—Cardiac disorder—Capecitabine—kidney cancer	0.000146	0.000605	CcSEcCtD
Gadoxetate—Cough—Paclitaxel—kidney cancer	0.000146	0.000604	CcSEcCtD
Gadoxetate—Asthenia—Sunitinib—kidney cancer	0.000146	0.000603	CcSEcCtD
Gadoxetate—Dyspnoea—Gemcitabine—kidney cancer	0.000145	0.000601	CcSEcCtD
Gadoxetate—Nausea—Vinblastine—kidney cancer	0.000145	0.0006	CcSEcCtD
Gadoxetate—Convulsion—Paclitaxel—kidney cancer	0.000145	0.000599	CcSEcCtD
Gadoxetate—Nausea—Everolimus—kidney cancer	0.000145	0.000598	CcSEcCtD
Gadoxetate—Diarrhoea—Sorafenib—kidney cancer	0.000145	0.000597	CcSEcCtD
Gadoxetate—ABCC4—Ectoderm Differentiation—PAX6—kidney cancer	0.000145	0.00612	CbGpPWpGaD
Gadoxetate—Pruritus—Sunitinib—kidney cancer	0.000144	0.000594	CcSEcCtD
Gadoxetate—Angiopathy—Capecitabine—kidney cancer	0.000143	0.000592	CcSEcCtD
Gadoxetate—Immune system disorder—Capecitabine—kidney cancer	0.000143	0.000589	CcSEcCtD
Gadoxetate—Chest pain—Paclitaxel—kidney cancer	0.000143	0.000589	CcSEcCtD
Gadoxetate—Mediastinal disorder—Capecitabine—kidney cancer	0.000142	0.000588	CcSEcCtD
Gadoxetate—Anxiety—Paclitaxel—kidney cancer	0.000142	0.000587	CcSEcCtD
Gadoxetate—Face oedema—Doxorubicin—kidney cancer	0.000142	0.000587	CcSEcCtD
Gadoxetate—Decreased appetite—Gemcitabine—kidney cancer	0.000142	0.000586	CcSEcCtD
Gadoxetate—Hypersensitivity—Dactinomycin—kidney cancer	0.000142	0.000586	CcSEcCtD
Gadoxetate—Chills—Capecitabine—kidney cancer	0.000142	0.000585	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000142	0.000585	CcSEcCtD
Gadoxetate—Arrhythmia—Capecitabine—kidney cancer	0.000141	0.000582	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000141	0.000582	CcSEcCtD
Gadoxetate—Discomfort—Paclitaxel—kidney cancer	0.000141	0.000582	CcSEcCtD
Gadoxetate—Fatigue—Gemcitabine—kidney cancer	0.000141	0.000581	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Vincristine—kidney cancer	0.000141	0.000581	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—RYR1—kidney cancer	0.00014	0.00595	CbGpPWpGaD
Gadoxetate—Dizziness—Sorafenib—kidney cancer	0.00014	0.000577	CcSEcCtD
Gadoxetate—Constipation—Gemcitabine—kidney cancer	0.00014	0.000577	CcSEcCtD
Gadoxetate—Nausea—Erlotinib—kidney cancer	0.00014	0.000577	CcSEcCtD
Gadoxetate—Dry mouth—Paclitaxel—kidney cancer	0.000139	0.000576	CcSEcCtD
Gadoxetate—Diarrhoea—Sunitinib—kidney cancer	0.000139	0.000575	CcSEcCtD
Gadoxetate—Asthenia—Dactinomycin—kidney cancer	0.000138	0.000571	CcSEcCtD
Gadoxetate—Blood creatinine increased—Doxorubicin—kidney cancer	0.000138	0.000569	CcSEcCtD
Gadoxetate—Dehydration—Doxorubicin—kidney cancer	0.000137	0.000565	CcSEcCtD
Gadoxetate—Oedema—Paclitaxel—kidney cancer	0.000137	0.000564	CcSEcCtD
Gadoxetate—Anaphylactic shock—Paclitaxel—kidney cancer	0.000137	0.000564	CcSEcCtD
Gadoxetate—Body temperature increased—Vincristine—kidney cancer	0.000136	0.000562	CcSEcCtD
Gadoxetate—Abdominal pain—Vincristine—kidney cancer	0.000136	0.000562	CcSEcCtD
Gadoxetate—Infection—Paclitaxel—kidney cancer	0.000136	0.000561	CcSEcCtD
Gadoxetate—Flatulence—Capecitabine—kidney cancer	0.000135	0.000559	CcSEcCtD
Gadoxetate—Dysgeusia—Capecitabine—kidney cancer	0.000135	0.000556	CcSEcCtD
Gadoxetate—Dizziness—Sunitinib—kidney cancer	0.000134	0.000556	CcSEcCtD
Gadoxetate—Feeling abnormal—Gemcitabine—kidney cancer	0.000134	0.000556	CcSEcCtD
Gadoxetate—Shock—Paclitaxel—kidney cancer	0.000134	0.000555	CcSEcCtD
Gadoxetate—Vomiting—Sorafenib—kidney cancer	0.000134	0.000555	CcSEcCtD
Gadoxetate—Nervous system disorder—Paclitaxel—kidney cancer	0.000134	0.000554	CcSEcCtD
Gadoxetate—Hypokalaemia—Doxorubicin—kidney cancer	0.000134	0.000553	CcSEcCtD
Gadoxetate—Tachycardia—Paclitaxel—kidney cancer	0.000133	0.000551	CcSEcCtD
Gadoxetate—Rash—Sorafenib—kidney cancer	0.000133	0.000551	CcSEcCtD
Gadoxetate—Dermatitis—Sorafenib—kidney cancer	0.000133	0.00055	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—SLC5A5—kidney cancer	0.000133	0.00562	CbGpPWpGaD
Gadoxetate—Back pain—Capecitabine—kidney cancer	0.000133	0.000549	CcSEcCtD
Gadoxetate—Skin disorder—Paclitaxel—kidney cancer	0.000133	0.000548	CcSEcCtD
Gadoxetate—Headache—Sorafenib—kidney cancer	0.000132	0.000547	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000132	0.00559	CbGpPWpGaD
Gadoxetate—Hyperhidrosis—Paclitaxel—kidney cancer	0.000132	0.000546	CcSEcCtD
Gadoxetate—Diarrhoea—Dactinomycin—kidney cancer	0.000132	0.000544	CcSEcCtD
Gadoxetate—Anorexia—Paclitaxel—kidney cancer	0.00013	0.000538	CcSEcCtD
Gadoxetate—Vision blurred—Capecitabine—kidney cancer	0.000129	0.000535	CcSEcCtD
Gadoxetate—Vomiting—Sunitinib—kidney cancer	0.000129	0.000534	CcSEcCtD
Gadoxetate—Body temperature increased—Gemcitabine—kidney cancer	0.000129	0.000533	CcSEcCtD
Gadoxetate—Tremor—Capecitabine—kidney cancer	0.000129	0.000532	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—SLC2A1—kidney cancer	0.000128	0.00543	CbGpPWpGaD
Gadoxetate—Rash—Sunitinib—kidney cancer	0.000128	0.00053	CcSEcCtD
Gadoxetate—Dermatitis—Sunitinib—kidney cancer	0.000128	0.000529	CcSEcCtD
Gadoxetate—Abdominal distension—Doxorubicin—kidney cancer	0.000128	0.000529	CcSEcCtD
Gadoxetate—Hypotension—Paclitaxel—kidney cancer	0.000128	0.000527	CcSEcCtD
Gadoxetate—Ill-defined disorder—Capecitabine—kidney cancer	0.000127	0.000527	CcSEcCtD
Gadoxetate—Headache—Sunitinib—kidney cancer	0.000127	0.000526	CcSEcCtD
Gadoxetate—Dysphagia—Doxorubicin—kidney cancer	0.000127	0.000525	CcSEcCtD
Gadoxetate—Hypersensitivity—Vincristine—kidney cancer	0.000127	0.000524	CcSEcCtD
Gadoxetate—Nausea—Sorafenib—kidney cancer	0.000126	0.000519	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—SLC5A5—kidney cancer	0.000125	0.00529	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000124	0.00525	CbGpPWpGaD
Gadoxetate—Malaise—Capecitabine—kidney cancer	0.000124	0.000512	CcSEcCtD
Gadoxetate—Vertigo—Capecitabine—kidney cancer	0.000123	0.00051	CcSEcCtD
Gadoxetate—Asthenia—Vincristine—kidney cancer	0.000123	0.00051	CcSEcCtD
Gadoxetate—Syncope—Capecitabine—kidney cancer	0.000123	0.000509	CcSEcCtD
Gadoxetate—Paraesthesia—Paclitaxel—kidney cancer	0.000123	0.000507	CcSEcCtD
Gadoxetate—Vomiting—Dactinomycin—kidney cancer	0.000122	0.000506	CcSEcCtD
Gadoxetate—Bronchitis—Doxorubicin—kidney cancer	0.000122	0.000505	CcSEcCtD
Gadoxetate—Dyspnoea—Paclitaxel—kidney cancer	0.000122	0.000503	CcSEcCtD
Gadoxetate—Palpitations—Capecitabine—kidney cancer	0.000121	0.000502	CcSEcCtD
Gadoxetate—Rash—Dactinomycin—kidney cancer	0.000121	0.000502	CcSEcCtD
Gadoxetate—Nausea—Sunitinib—kidney cancer	0.000121	0.000499	CcSEcCtD
Gadoxetate—Loss of consciousness—Capecitabine—kidney cancer	0.000121	0.000499	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—SLC2A1—kidney cancer	0.000121	0.00511	CbGpPWpGaD
Gadoxetate—Cough—Capecitabine—kidney cancer	0.00012	0.000495	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—EGR1—kidney cancer	0.000119	0.00504	CbGpPWpGaD
Gadoxetate—Decreased appetite—Paclitaxel—kidney cancer	0.000119	0.000491	CcSEcCtD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000118	0.005	CbGpPWpGaD
Gadoxetate—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000118	0.000487	CcSEcCtD
Gadoxetate—Fatigue—Paclitaxel—kidney cancer	0.000118	0.000487	CcSEcCtD
Gadoxetate—Diarrhoea—Vincristine—kidney cancer	0.000118	0.000486	CcSEcCtD
Gadoxetate—Asthenia—Gemcitabine—kidney cancer	0.000117	0.000484	CcSEcCtD
Gadoxetate—Chest pain—Capecitabine—kidney cancer	0.000117	0.000483	CcSEcCtD
Gadoxetate—Constipation—Paclitaxel—kidney cancer	0.000117	0.000483	CcSEcCtD
Gadoxetate—Anxiety—Capecitabine—kidney cancer	0.000117	0.000482	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000116	0.00048	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—L1CAM—kidney cancer	0.000116	0.00489	CbGpPWpGaD
Gadoxetate—Discomfort—Capecitabine—kidney cancer	0.000116	0.000477	CcSEcCtD
Gadoxetate—Pruritus—Gemcitabine—kidney cancer	0.000115	0.000477	CcSEcCtD
Gadoxetate—Dry mouth—Capecitabine—kidney cancer	0.000114	0.000473	CcSEcCtD
Gadoxetate—Nausea—Dactinomycin—kidney cancer	0.000114	0.000472	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—ITPR2—kidney cancer	0.000114	0.00484	CbGpPWpGaD
Gadoxetate—Dizziness—Vincristine—kidney cancer	0.000114	0.00047	CcSEcCtD
Gadoxetate—Feeling abnormal—Paclitaxel—kidney cancer	0.000113	0.000465	CcSEcCtD
Gadoxetate—Oedema—Capecitabine—kidney cancer	0.000112	0.000463	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—EGR1—kidney cancer	0.000112	0.00474	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000112	0.00474	CbGpPWpGaD
Gadoxetate—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000112	0.000462	CcSEcCtD
Gadoxetate—Diarrhoea—Gemcitabine—kidney cancer	0.000112	0.000461	CcSEcCtD
Gadoxetate—Renal failure—Doxorubicin—kidney cancer	0.000111	0.00046	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000111	0.00471	CbGpPWpGaD
Gadoxetate—Infection—Capecitabine—kidney cancer	0.000111	0.00046	CcSEcCtD
Gadoxetate—Shock—Capecitabine—kidney cancer	0.00011	0.000456	CcSEcCtD
Gadoxetate—Conjunctivitis—Doxorubicin—kidney cancer	0.00011	0.000455	CcSEcCtD
Gadoxetate—Nervous system disorder—Capecitabine—kidney cancer	0.00011	0.000454	CcSEcCtD
Gadoxetate—Tachycardia—Capecitabine—kidney cancer	0.000109	0.000452	CcSEcCtD
Gadoxetate—Vomiting—Vincristine—kidney cancer	0.000109	0.000452	CcSEcCtD
Gadoxetate—Skin disorder—Capecitabine—kidney cancer	0.000109	0.00045	CcSEcCtD
Gadoxetate—Urticaria—Paclitaxel—kidney cancer	0.000109	0.000448	CcSEcCtD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—TP53—kidney cancer	0.000108	0.00459	CbGpPWpGaD
Gadoxetate—Rash—Vincristine—kidney cancer	0.000108	0.000448	CcSEcCtD
Gadoxetate—Hyperhidrosis—Capecitabine—kidney cancer	0.000108	0.000448	CcSEcCtD
Gadoxetate—Dermatitis—Vincristine—kidney cancer	0.000108	0.000448	CcSEcCtD
Gadoxetate—Body temperature increased—Paclitaxel—kidney cancer	0.000108	0.000446	CcSEcCtD
Gadoxetate—Abdominal pain—Paclitaxel—kidney cancer	0.000108	0.000446	CcSEcCtD
Gadoxetate—Headache—Vincristine—kidney cancer	0.000108	0.000445	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—GSTP1—kidney cancer	0.000107	0.00453	CbGpPWpGaD
Gadoxetate—Anorexia—Capecitabine—kidney cancer	0.000107	0.000442	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—SLC5A5—kidney cancer	0.000105	0.00446	CbGpPWpGaD
Gadoxetate—Hypotension—Capecitabine—kidney cancer	0.000105	0.000433	CcSEcCtD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000105	0.00443	CbGpPWpGaD
Gadoxetate—Vomiting—Gemcitabine—kidney cancer	0.000104	0.000429	CcSEcCtD
Gadoxetate—Rash—Gemcitabine—kidney cancer	0.000103	0.000425	CcSEcCtD
Gadoxetate—Dermatitis—Gemcitabine—kidney cancer	0.000103	0.000425	CcSEcCtD
Gadoxetate—Headache—Gemcitabine—kidney cancer	0.000102	0.000422	CcSEcCtD
Gadoxetate—Nausea—Vincristine—kidney cancer	0.000102	0.000422	CcSEcCtD
Gadoxetate—Rhinitis—Doxorubicin—kidney cancer	0.000102	0.000421	CcSEcCtD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—TP53—kidney cancer	0.000102	0.00432	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—SLC2A1—kidney cancer	0.000102	0.00431	CbGpPWpGaD
Gadoxetate—Hypoaesthesia—Doxorubicin—kidney cancer	0.000101	0.000418	CcSEcCtD
Gadoxetate—Paraesthesia—Capecitabine—kidney cancer	0.000101	0.000416	CcSEcCtD
Gadoxetate—Hypersensitivity—Paclitaxel—kidney cancer	0.000101	0.000416	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—GSTP1—kidney cancer	0.000101	0.00426	CbGpPWpGaD
Gadoxetate—Connective tissue disorder—Doxorubicin—kidney cancer	0.0001	0.000413	CcSEcCtD
Gadoxetate—Dyspnoea—Capecitabine—kidney cancer	0.0001	0.000413	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—GSTM1—kidney cancer	9.84e-05	0.00416	CbGpPWpGaD
Gadoxetate—Asthenia—Paclitaxel—kidney cancer	9.8e-05	0.000405	CcSEcCtD
Gadoxetate—Decreased appetite—Capecitabine—kidney cancer	9.75e-05	0.000403	CcSEcCtD
Gadoxetate—Nausea—Gemcitabine—kidney cancer	9.69e-05	0.0004	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Capecitabine—kidney cancer	9.68e-05	0.0004	CcSEcCtD
Gadoxetate—Fatigue—Capecitabine—kidney cancer	9.67e-05	0.000399	CcSEcCtD
Gadoxetate—Pruritus—Paclitaxel—kidney cancer	9.67e-05	0.000399	CcSEcCtD
Gadoxetate—Constipation—Capecitabine—kidney cancer	9.59e-05	0.000396	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—EGR1—kidney cancer	9.45e-05	0.004	CbGpPWpGaD
Gadoxetate—Flushing—Doxorubicin—kidney cancer	9.44e-05	0.00039	CcSEcCtD
Gadoxetate—Cardiac disorder—Doxorubicin—kidney cancer	9.44e-05	0.00039	CcSEcCtD
Gadoxetate—Diarrhoea—Paclitaxel—kidney cancer	9.35e-05	0.000386	CcSEcCtD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	9.28e-05	0.00393	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—GSTM1—kidney cancer	9.25e-05	0.00391	CbGpPWpGaD
Gadoxetate—Feeling abnormal—Capecitabine—kidney cancer	9.24e-05	0.000382	CcSEcCtD
Gadoxetate—Angiopathy—Doxorubicin—kidney cancer	9.23e-05	0.000381	CcSEcCtD
Gadoxetate—Immune system disorder—Doxorubicin—kidney cancer	9.19e-05	0.00038	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Capecitabine—kidney cancer	9.17e-05	0.000379	CcSEcCtD
Gadoxetate—Mediastinal disorder—Doxorubicin—kidney cancer	9.17e-05	0.000379	CcSEcCtD
Gadoxetate—Chills—Doxorubicin—kidney cancer	9.13e-05	0.000377	CcSEcCtD
Gadoxetate—Arrhythmia—Doxorubicin—kidney cancer	9.09e-05	0.000375	CcSEcCtD
Gadoxetate—Dizziness—Paclitaxel—kidney cancer	9.03e-05	0.000373	CcSEcCtD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	8.96e-05	0.00379	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ANXA2—kidney cancer	8.94e-05	0.00379	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC5A3—kidney cancer	8.94e-05	0.00379	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ATP7B—kidney cancer	8.94e-05	0.00379	CbGpPWpGaD
Gadoxetate—Urticaria—Capecitabine—kidney cancer	8.91e-05	0.000368	CcSEcCtD
Gadoxetate—Body temperature increased—Capecitabine—kidney cancer	8.86e-05	0.000366	CcSEcCtD
Gadoxetate—Abdominal pain—Capecitabine—kidney cancer	8.86e-05	0.000366	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—ANXA2—kidney cancer	8.76e-05	0.00371	CbGpPWpGaD
Gadoxetate—Flatulence—Doxorubicin—kidney cancer	8.73e-05	0.000361	CcSEcCtD
Gadoxetate—Vomiting—Paclitaxel—kidney cancer	8.69e-05	0.000359	CcSEcCtD
Gadoxetate—Dysgeusia—Doxorubicin—kidney cancer	8.67e-05	0.000358	CcSEcCtD
Gadoxetate—Rash—Paclitaxel—kidney cancer	8.61e-05	0.000356	CcSEcCtD
Gadoxetate—Dermatitis—Paclitaxel—kidney cancer	8.61e-05	0.000356	CcSEcCtD
Gadoxetate—Back pain—Doxorubicin—kidney cancer	8.57e-05	0.000354	CcSEcCtD
Gadoxetate—Headache—Paclitaxel—kidney cancer	8.56e-05	0.000354	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—GSTP1—kidney cancer	8.49e-05	0.00359	CbGpPWpGaD
Gadoxetate—Vision blurred—Doxorubicin—kidney cancer	8.35e-05	0.000345	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	8.34e-05	0.00353	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Capecitabine—kidney cancer	8.26e-05	0.000341	CcSEcCtD
Gadoxetate—Ill-defined disorder—Doxorubicin—kidney cancer	8.22e-05	0.000339	CcSEcCtD
Gadoxetate—Agitation—Doxorubicin—kidney cancer	8.14e-05	0.000336	CcSEcCtD
Gadoxetate—Nausea—Paclitaxel—kidney cancer	8.12e-05	0.000335	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ATP7B—kidney cancer	8.07e-05	0.00342	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC5A3—kidney cancer	8.07e-05	0.00342	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ANXA2—kidney cancer	8.07e-05	0.00342	CbGpPWpGaD
Gadoxetate—Asthenia—Capecitabine—kidney cancer	8.04e-05	0.000332	CcSEcCtD
Gadoxetate—Malaise—Doxorubicin—kidney cancer	7.99e-05	0.00033	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—ACY1—kidney cancer	7.97e-05	0.00337	CbGpPWpGaD
Gadoxetate—Vertigo—Doxorubicin—kidney cancer	7.96e-05	0.000329	CcSEcCtD
Gadoxetate—Syncope—Doxorubicin—kidney cancer	7.94e-05	0.000328	CcSEcCtD
Gadoxetate—Pruritus—Capecitabine—kidney cancer	7.93e-05	0.000328	CcSEcCtD
Gadoxetate—Palpitations—Doxorubicin—kidney cancer	7.83e-05	0.000323	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—GSTM1—kidney cancer	7.8e-05	0.0033	CbGpPWpGaD
Gadoxetate—Loss of consciousness—Doxorubicin—kidney cancer	7.78e-05	0.000322	CcSEcCtD
Gadoxetate—Cough—Doxorubicin—kidney cancer	7.73e-05	0.000319	CcSEcCtD
Gadoxetate—Convulsion—Doxorubicin—kidney cancer	7.67e-05	0.000317	CcSEcCtD
Gadoxetate—Diarrhoea—Capecitabine—kidney cancer	7.67e-05	0.000317	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ATP7B—kidney cancer	7.59e-05	0.00321	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC5A3—kidney cancer	7.59e-05	0.00321	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ANXA2—kidney cancer	7.59e-05	0.00321	CbGpPWpGaD
Gadoxetate—Chest pain—Doxorubicin—kidney cancer	7.54e-05	0.000311	CcSEcCtD
Gadoxetate—Anxiety—Doxorubicin—kidney cancer	7.51e-05	0.00031	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.49e-05	0.000309	CcSEcCtD
Gadoxetate—Discomfort—Doxorubicin—kidney cancer	7.45e-05	0.000308	CcSEcCtD
Gadoxetate—Dizziness—Capecitabine—kidney cancer	7.41e-05	0.000306	CcSEcCtD
Gadoxetate—Dry mouth—Doxorubicin—kidney cancer	7.37e-05	0.000305	CcSEcCtD
Gadoxetate—SLCO1B1—renal system—kidney cancer	7.3e-05	0.0999	CbGeAlD
Gadoxetate—ABCC4—Hemostasis—KCNMA1—kidney cancer	7.26e-05	0.00307	CbGpPWpGaD
Gadoxetate—Oedema—Doxorubicin—kidney cancer	7.23e-05	0.000299	CcSEcCtD
Gadoxetate—Anaphylactic shock—Doxorubicin—kidney cancer	7.23e-05	0.000299	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—ACY1—kidney cancer	7.19e-05	0.00305	CbGpPWpGaD
Gadoxetate—Infection—Doxorubicin—kidney cancer	7.18e-05	0.000297	CcSEcCtD
Gadoxetate—Vomiting—Capecitabine—kidney cancer	7.13e-05	0.000295	CcSEcCtD
Gadoxetate—Shock—Doxorubicin—kidney cancer	7.11e-05	0.000294	CcSEcCtD
Gadoxetate—Nervous system disorder—Doxorubicin—kidney cancer	7.09e-05	0.000293	CcSEcCtD
Gadoxetate—Rash—Capecitabine—kidney cancer	7.07e-05	0.000292	CcSEcCtD
Gadoxetate—Dermatitis—Capecitabine—kidney cancer	7.06e-05	0.000292	CcSEcCtD
Gadoxetate—SLCO1B1—kidney—kidney cancer	7.06e-05	0.0966	CbGeAlD
Gadoxetate—Tachycardia—Doxorubicin—kidney cancer	7.05e-05	0.000291	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—IGF2—kidney cancer	7.03e-05	0.00298	CbGpPWpGaD
Gadoxetate—Headache—Capecitabine—kidney cancer	7.02e-05	0.00029	CcSEcCtD
Gadoxetate—Skin disorder—Doxorubicin—kidney cancer	7.02e-05	0.00029	CcSEcCtD
Gadoxetate—Hyperhidrosis—Doxorubicin—kidney cancer	6.99e-05	0.000289	CcSEcCtD
Gadoxetate—ABCC3—renal system—kidney cancer	6.93e-05	0.0948	CbGeAlD
Gadoxetate—Anorexia—Doxorubicin—kidney cancer	6.89e-05	0.000285	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.8e-05	0.00288	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PDHB—kidney cancer	6.78e-05	0.00287	CbGpPWpGaD
Gadoxetate—Hypotension—Doxorubicin—kidney cancer	6.75e-05	0.000279	CcSEcCtD
Gadoxetate—ABCC3—kidney—kidney cancer	6.7e-05	0.0916	CbGeAlD
Gadoxetate—Nausea—Capecitabine—kidney cancer	6.66e-05	0.000275	CcSEcCtD
Gadoxetate—ABCC4—Platelet degranulation—VEGFA—kidney cancer	6.65e-05	0.00281	CbGpPWpGaD
Gadoxetate—Paraesthesia—Doxorubicin—kidney cancer	6.49e-05	0.000268	CcSEcCtD
Gadoxetate—Dyspnoea—Doxorubicin—kidney cancer	6.44e-05	0.000266	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ATP7B—kidney cancer	6.4e-05	0.00271	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6.4e-05	0.00271	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ANXA2—kidney cancer	6.4e-05	0.00271	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CCBL1—kidney cancer	6.37e-05	0.0027	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—GRB7—kidney cancer	6.34e-05	0.00268	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	6.33e-05	0.00268	CbGpPWpGaD
Gadoxetate—ABCC4—nephron tubule—kidney cancer	6.29e-05	0.0861	CbGeAlD
Gadoxetate—Decreased appetite—Doxorubicin—kidney cancer	6.28e-05	0.00026	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.24e-05	0.000258	CcSEcCtD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	6.24e-05	0.00264	CbGpPWpGaD
Gadoxetate—Fatigue—Doxorubicin—kidney cancer	6.23e-05	0.000257	CcSEcCtD
Gadoxetate—Constipation—Doxorubicin—kidney cancer	6.18e-05	0.000255	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.14e-05	0.0026	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PDHB—kidney cancer	6.12e-05	0.00259	CbGpPWpGaD
Gadoxetate—ABCC2—nephron tubule—kidney cancer	6.09e-05	0.0833	CbGeAlD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	6.02e-05	0.00255	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ATP7B—kidney cancer	6.01e-05	0.00254	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6.01e-05	0.00254	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ANXA2—kidney cancer	6.01e-05	0.00254	CbGpPWpGaD
Gadoxetate—Feeling abnormal—Doxorubicin—kidney cancer	5.96e-05	0.000246	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Doxorubicin—kidney cancer	5.91e-05	0.000244	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—ITPR2—kidney cancer	5.89e-05	0.00249	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.76e-05	0.00244	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CCBL1—kidney cancer	5.75e-05	0.00243	CbGpPWpGaD
Gadoxetate—Urticaria—Doxorubicin—kidney cancer	5.74e-05	0.000237	CcSEcCtD
Gadoxetate—ABCC4—renal system—kidney cancer	5.72e-05	0.0782	CbGeAlD
Gadoxetate—Body temperature increased—Doxorubicin—kidney cancer	5.71e-05	0.000236	CcSEcCtD
Gadoxetate—Abdominal pain—Doxorubicin—kidney cancer	5.71e-05	0.000236	CcSEcCtD
Gadoxetate—ABCC2—renal system—kidney cancer	5.53e-05	0.0757	CbGeAlD
Gadoxetate—SLCO1B3—Metabolism—PPAT—kidney cancer	5.53e-05	0.00234	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GLIPR1—kidney cancer	5.53e-05	0.00234	CbGpPWpGaD
Gadoxetate—ABCC4—kidney—kidney cancer	5.53e-05	0.0756	CbGeAlD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.46e-05	0.00231	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	5.4e-05	0.00229	CbGpPWpGaD
Gadoxetate—ABCC4—cortex of kidney—kidney cancer	5.38e-05	0.0737	CbGeAlD
Gadoxetate—SLCO1B1—Metabolism—ACY1—kidney cancer	5.36e-05	0.00227	CbGpPWpGaD
Gadoxetate—ABCC2—kidney—kidney cancer	5.35e-05	0.0732	CbGeAlD
Gadoxetate—Hypersensitivity—Doxorubicin—kidney cancer	5.32e-05	0.00022	CcSEcCtD
Gadoxetate—ABCC2—cortex of kidney—kidney cancer	5.21e-05	0.0713	CbGeAlD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.2e-05	0.0022	CbGpPWpGaD
Gadoxetate—Asthenia—Doxorubicin—kidney cancer	5.19e-05	0.000214	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—FH—kidney cancer	5.14e-05	0.00217	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—APRT—kidney cancer	5.14e-05	0.00217	CbGpPWpGaD
Gadoxetate—Pruritus—Doxorubicin—kidney cancer	5.11e-05	0.000211	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.02e-05	0.00213	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PPAT—kidney cancer	4.99e-05	0.00211	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GLIPR1—kidney cancer	4.99e-05	0.00211	CbGpPWpGaD
Gadoxetate—Diarrhoea—Doxorubicin—kidney cancer	4.94e-05	0.000204	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.92e-05	0.00208	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—CTNNB1—kidney cancer	4.88e-05	0.00207	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.87e-05	0.00206	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GPC3—kidney cancer	4.83e-05	0.00204	CbGpPWpGaD
Gadoxetate—Dizziness—Doxorubicin—kidney cancer	4.78e-05	0.000197	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.72e-05	0.002	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CA2—kidney cancer	4.7e-05	0.00199	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—APRT—kidney cancer	4.64e-05	0.00196	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—FH—kidney cancer	4.64e-05	0.00196	CbGpPWpGaD
Gadoxetate—Vomiting—Doxorubicin—kidney cancer	4.6e-05	0.00019	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—ALAD—kidney cancer	4.58e-05	0.00194	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.57e-05	0.00193	CbGpPWpGaD
Gadoxetate—Rash—Doxorubicin—kidney cancer	4.56e-05	0.000188	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.56e-05	0.00193	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PDHB—kidney cancer	4.56e-05	0.00193	CbGpPWpGaD
Gadoxetate—Dermatitis—Doxorubicin—kidney cancer	4.55e-05	0.000188	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.53e-05	0.00192	CbGpPWpGaD
Gadoxetate—Headache—Doxorubicin—kidney cancer	4.53e-05	0.000187	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—ST3GAL2—kidney cancer	4.47e-05	0.00189	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ALDH1A1—kidney cancer	4.37e-05	0.00185	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GPC3—kidney cancer	4.36e-05	0.00184	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IFNA1—kidney cancer	4.32e-05	0.00183	CbGpPWpGaD
Gadoxetate—Nausea—Doxorubicin—kidney cancer	4.29e-05	0.000177	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—CCBL1—kidney cancer	4.28e-05	0.00181	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.26e-05	0.0018	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CA2—kidney cancer	4.24e-05	0.00179	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC5A3—kidney cancer	4.19e-05	0.00177	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PGK1—kidney cancer	4.19e-05	0.00177	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ALAD—kidney cancer	4.13e-05	0.00175	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.11e-05	0.00174	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—LDHB—kidney cancer	4.11e-05	0.00174	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ST3GAL2—kidney cancer	4.03e-05	0.00171	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IFNA2—kidney cancer	4.02e-05	0.0017	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4e-05	0.00169	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—MYC—kidney cancer	3.95e-05	0.00167	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ALDH1A1—kidney cancer	3.94e-05	0.00167	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.87e-05	0.00164	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—RAF1—kidney cancer	3.87e-05	0.00164	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.86e-05	0.00164	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PGK1—kidney cancer	3.78e-05	0.0016	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC5A3—kidney cancer	3.78e-05	0.0016	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GLIPR1—kidney cancer	3.71e-05	0.00157	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPAT—kidney cancer	3.71e-05	0.00157	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—LDHB—kidney cancer	3.71e-05	0.00157	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.67e-05	0.00155	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.63e-05	0.00154	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IGF2—kidney cancer	3.62e-05	0.00153	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.6e-05	0.00152	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CA9—kidney cancer	3.56e-05	0.00151	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.48e-05	0.00147	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—IL2—kidney cancer	3.47e-05	0.00147	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—FH—kidney cancer	3.45e-05	0.00146	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—APRT—kidney cancer	3.45e-05	0.00146	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.37e-05	0.00143	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.37e-05	0.00143	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.26e-05	0.00138	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GPC3—kidney cancer	3.25e-05	0.00137	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.25e-05	0.00137	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CA9—kidney cancer	3.21e-05	0.00136	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.17e-05	0.00134	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CA2—kidney cancer	3.16e-05	0.00134	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.14e-05	0.00133	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ALAD—kidney cancer	3.08e-05	0.0013	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.06e-05	0.0013	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.05e-05	0.00129	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CRABP1—kidney cancer	3.03e-05	0.00128	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ST3GAL2—kidney cancer	3e-05	0.00127	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.95e-05	0.00125	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ALDH1A1—kidney cancer	2.94e-05	0.00124	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ITPR2—kidney cancer	2.82e-05	0.00119	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PGK1—kidney cancer	2.81e-05	0.00119	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC5A3—kidney cancer	2.81e-05	0.00119	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	2.79e-05	0.00118	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—LDHB—kidney cancer	2.76e-05	0.00117	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CRABP1—kidney cancer	2.73e-05	0.00116	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.65e-05	0.00112	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.6e-05	0.0011	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.57e-05	0.00109	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTT1—kidney cancer	2.57e-05	0.00109	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ACHE—kidney cancer	2.57e-05	0.00109	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ITPR2—kidney cancer	2.54e-05	0.00108	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SCARB1—kidney cancer	2.43e-05	0.00103	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.42e-05	0.00102	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTGS1—kidney cancer	2.41e-05	0.00102	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CA9—kidney cancer	2.39e-05	0.00101	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PSMD7—kidney cancer	2.36e-05	0.000999	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.34e-05	0.000991	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.34e-05	0.00099	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ACHE—kidney cancer	2.32e-05	0.00098	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTT1—kidney cancer	2.32e-05	0.00098	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	2.3e-05	0.000975	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—BCHE—kidney cancer	2.24e-05	0.000947	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC5A5—kidney cancer	2.21e-05	0.000935	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SCARB1—kidney cancer	2.19e-05	0.000928	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTGS1—kidney cancer	2.17e-05	0.000919	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC2A1—kidney cancer	2.13e-05	0.000903	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PSMD7—kidney cancer	2.13e-05	0.000901	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.07e-05	0.000876	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—RAF1—kidney cancer	2.03e-05	0.000861	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CRABP1—kidney cancer	2.03e-05	0.000861	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—BCHE—kidney cancer	2.02e-05	0.000854	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—RAF1—kidney cancer	1.99e-05	0.000844	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC5A5—kidney cancer	1.99e-05	0.000844	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC2A1—kidney cancer	1.93e-05	0.000815	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ITPR2—kidney cancer	1.89e-05	0.000801	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.87e-05	0.000791	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.84e-05	0.000777	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.81e-05	0.000764	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IL2—kidney cancer	1.79e-05	0.000757	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTP1—kidney cancer	1.78e-05	0.000753	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.74e-05	0.000738	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—RAF1—kidney cancer	1.73e-05	0.000731	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTT1—kidney cancer	1.72e-05	0.00073	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ACHE—kidney cancer	1.72e-05	0.00073	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ABCB1—kidney cancer	1.68e-05	0.000713	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTM1—kidney cancer	1.64e-05	0.000692	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SCARB1—kidney cancer	1.63e-05	0.000691	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.63e-05	0.000689	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTGS1—kidney cancer	1.62e-05	0.000684	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTP1—kidney cancer	1.61e-05	0.00068	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PSMD7—kidney cancer	1.59e-05	0.000671	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP1A1—kidney cancer	1.55e-05	0.000656	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ABCB1—kidney cancer	1.52e-05	0.000643	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFA—kidney cancer	1.52e-05	0.000643	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—BCHE—kidney cancer	1.5e-05	0.000636	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC5A5—kidney cancer	1.48e-05	0.000628	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTM1—kidney cancer	1.48e-05	0.000625	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.46e-05	0.000616	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MAPK3—kidney cancer	1.44e-05	0.000608	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC2A1—kidney cancer	1.43e-05	0.000607	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP1A1—kidney cancer	1.4e-05	0.000592	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.39e-05	0.000589	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MAPK1—kidney cancer	1.37e-05	0.000579	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.37e-05	0.000579	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—KRAS—kidney cancer	1.29e-05	0.000547	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.27e-05	0.000539	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.21e-05	0.000513	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTP1—kidney cancer	1.2e-05	0.000506	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CA—kidney cancer	1.19e-05	0.000502	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—POMC—kidney cancer	1.16e-05	0.000489	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.15e-05	0.000486	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TP53—kidney cancer	1.15e-05	0.000486	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ABCB1—kidney cancer	1.13e-05	0.000479	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTM1—kidney cancer	1.1e-05	0.000465	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—POMC—kidney cancer	1.04e-05	0.000441	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP1A1—kidney cancer	1.04e-05	0.000441	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTGS2—kidney cancer	9.22e-06	0.00039	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.56e-06	0.000362	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTGS2—kidney cancer	8.32e-06	0.000352	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTEN—kidney cancer	8.04e-06	0.00034	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—POMC—kidney cancer	7.77e-06	0.000329	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTEN—kidney cancer	7.25e-06	0.000307	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTGS2—kidney cancer	6.19e-06	0.000262	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CA—kidney cancer	5.67e-06	0.00024	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTEN—kidney cancer	5.4e-06	0.000229	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CA—kidney cancer	5.12e-06	0.000217	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CA—kidney cancer	3.81e-06	0.000161	CbGpPWpGaD
